Using Community Health Workers to Improve Clinical Outcomes Among People Living with HIV: A Randomized Controlled Trial
- 21 March 2013
- journal article
- research article
- Published by Springer Nature in AIDS and Behavior
- Vol. 17 (9) , 2927-2934
Abstract
AIDS-related mortality remains a leading cause of preventable death among African-Americans. We sought to determine if community health workers could improve clinical outcomes among vulnerable African-Americans living with HIV in Miami, Florida. We recruited 91 medically indigent persons with HIV viral loads ≥1,000 and/or a CD4 cell count ≤350. Patients were randomized to a community health worker (CHW) intervention or control group. Viral load and CD4 cell count data were abstracted from electronic medical records. At 12 months, the mean VL in the intervention group was log 0.9 copies/μL lower than the control group. The CD4 counts were not significantly different among the groups. Compared to the control group, patients randomized to CHWs experienced statistically significant improvements in HIV viral load. Larger multi-site studies of longer duration are needed to determine whether CHWs should be incorporated into standard treatment models for vulnerable populations living with HIV. La mortalidad relacionada con el SIDA sigue siendo la principal causa de muerte evitable entre los afro-americanos. Nuestro objetivo era determinar si los promotores de salud podrían mejorar los resultados clínicos entre africano-americanos que viven con el VIH en Miami, Florida. Reclutamos a noventa y un personas médicamente indigentes con cargas virales de VIH >1,000 y/o un recuento de células CD4 <350. Los pacientes fueron asignados al azar a un grupo de intervención con un trabajador de salud comunitaria (TSC)/promotor o al grupo control. Los datos de carga viral y recuento de células CD4 fueron extraídos de registros médicos electrónicos. En doce meses, el promedio del VL en el grupo de intervención fué de 0,9 log copias/μL más bajos que los del grupo control. Los recuentos de células CD4 no fueron significativamente diferentes entre los grupos. En comparación con el grupo control, los pacientes asignados al azar a los promotores/TSC experimentaron mejoras estadísticamente significativas en la carga viral de VIH. Estudios de mayor duración y de sitios múltiples son necesarios para determinar si los promotores/TSC deben ser incorporados en los modelos estándar de tratamiento para las poblaciones vulnerables que viven con el VIH.Keywords
This publication has 19 references indexed in Scilit:
- Can community health workers improve adherence to highly active antiretroviral therapy in the USA? A review of the literatureHIV Medicine, 2011
- Factors affecting recruitment and retention of community health workers in a newborn care intervention in BangladeshHuman Resources for Health, 2010
- A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance usersAIDS, 2007
- Evaluation of Community Action Against Asthma: A Community Health Worker Intervention to Improve Children's Asthma-Related Health by Reducing Household Environmental Triggers for AsthmaHealth Education & Behavior, 2007
- Impact of Enhanced Services on Virologic Outcomes in a Directly Administered Antiretroviral Therapy Trial for HIV-Infected Drug UsersJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Improving Diabetes Care and Health Measures Among Hispanics Using Community Health WorkersHealth Education & Behavior, 2006
- Comparisons of Causes of Death and Mortality Rates Among HIV-Infected PersonsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Incidence and Impact of Posttraumatic Stress Disorder and Comorbid Depression on Adherence to HAART and CD4 + Counts in People Living with HIVAIDS Patient Care and STDs, 2005
- Pilot Study of Directly Observed Therapy in Highly Nonadherent HIV-Infected Patients in an Urban Community-Based InstitutionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy).2001